BioSpace News Archive

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

In last few years, therapeutic antibodies have emerged out to be mainstream approach in the management of cancer.

Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced two new studies focused on how the use of machine learning on real-world data can be used to power precision medicine solutions.

Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the treatment of genitourinary tumors and other major diseases announced that ANTICIPATE Study will be presented at the 2022 American Society of Clinical Oncology (ASCO) annual meeting (3-7 June) in Chicago.

The global preimplantation genetics diagnosis (pgd) market was valued at $81,520.20 thousand in 2020, and is projected to reach $217,190.00 thousand by 2030, growing at a CAGR of 10.8% from 2021 to 2030.

According to Report Study, the global femtech market was surpassed at USD 5.2 billion in 2021 and is expected to hit around USD 13.3 billion by 2030, growing at a CAGR of 11.0% from 2022 to 2030.

Biosurgery Market size was USD 11.45 billion in 2020 and is expected to register a revenue CAGR of 5.4% during the forecast period.

Magnetic Resonance Imaging Market is projected to grow at a rate of 4.6% in terms of value, from 2020 to reach USD 8,840.3 Million by 2028.

Surgical Devices Market size was USD 9.72 billion in 2020 and is expected to register a revenue CAGR of 9.6% during the forecast period.

Neuromodulation Market is forecast to reach USD 10.86 Billion by 2028, according to a new report by Reports and Data.